FDA Drug Recalls

Recalls / Class II

Class IID-0732-2023

Product

heparin added to 0.9% sodium chloride, 5,000 units/500 mL* (10 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7023-1.

Affected lot / code info
Lot # 37-888736, 37-888769, Exp 05/02/2023; 37-890465, 37-890483, Exp 05/09/2023; 37-892088, 37-892117, 37-892119, 37-892145, Exp 05/16/2023; 37-893759, 37-893765, Exp 05/23/2023; 37-895742, 37-895751, Exp 05/30/2023

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6580 Snowdrift Rd Ste 100, N/A, Allentown, Pennsylvania 18106-9331

Distribution

Quantity
5207 bags
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-04-28
FDA classified
2023-05-19
Posted by FDA
2023-05-31
Terminated
2025-06-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0732-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.